Intra‐articular gene delivery and expression of interleukin‐1Ra mediated by self‐complementary adeno‐associated virus
- 21 April 2009
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 11 (7) , 605-614
Abstract
Background: The adeno‐associated virus (AAV) has many safety features that favor its use in the treatment of arthritic conditions; however, the conventional, single‐stranded vector is inefficient for gene delivery to fibroblastic cells that primarily populate articular tissues. This has been attributed to the inability of these cells to convert the vector to a double‐stranded form. To overcome this, we evaluated double‐stranded self‐complementary (sc) AAV as a vehicle for intra‐articular gene delivery.Methods: Conventional and scAAV vectors were used to infect lapine articular fibroblasts in culture to determine transduction efficiency, transgene expression levels, and nuclear trafficking. scAAV containing the cDNA for interleukin (IL)‐1 receptor antagonist (Ra) was delivered to the joints of naïve rabbits and those with IL‐1β‐induced arthritis. From lavage of the joint space, levels of transgenic expression and persistence were measured by enzyme‐linked immunosorbent assay. Infiltrating leukocytes were quantified using a hemocytometer.Results: Transgene expression from scAAV had an earlier onset and was approximately 25‐fold greater than conventional AAV despite the presence of similar numbers of viral genomes in the nuclei of infected cells. Fibroblasts transduced with scAAV produced amounts of IL1‐Ra comparable to those transduced with adenoviral and lentiviral vectors. IL1‐Ra was present in lavage fluid of most animals for 2 weeks in sufficient quantities to inhibit inflammation of the IL‐1β‐driven model. Once lost, neither subsequent inflammatory events, nor re‐administration of the virus could re‐establish transgene expression.Conclusions: scAAV‐mediated intra‐articular gene transfer is robust and similarly efficient in both normal and inflamed joints; the resulting transgenic expression is sufficient to achieve biological relevance in joints of human proportion. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 56 references indexed in Scilit:
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower dosesProceedings of the National Academy of Sciences, 2008
- Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agentAnnals of the Rheumatic Diseases, 2007
- Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in ratsJournal of General Virology, 2007
- Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectorsVirology, 2006
- Inflammatory cytokine regulation of transgene expression in human fibroblast‐like synoviocytes infected with adeno‐associated virusArthritis & Rheumatism, 2006
- Adeno-associated virus vectors: potential applications for cancer gene therapyCancer Gene Therapy, 2005
- Successful Gene Therapy via Intraarticular Injection of Adenovirus Vector Containing CTLA4IgG in a Murine Model of Type II Collagen-Induced ArthritisHuman Gene Therapy, 2001
- Adeno-Associated Virus Type 2-Mediated Gene Transfer: Altered Endocytic Processing Enhances Transduction Efficiency in Murine FibroblastsJournal of Virology, 2001
- Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome DegradationJournal of Virology, 2001
- Selective extraction of polyoma DNA from infected mouse cell culturesJournal of Molecular Biology, 1967